Percutaneous Liver Biopsy
Sponsors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Taiwan University Hospital, Rutgers, The State University of New Jersey, Brigham and Women's Hospital, Asian Institute of Gastroenterology, India
Conditions
Alcoholic HepatitisBiopsyBrain DeathChronic Hepatitis BChronic Hepatitis CChronic Liver Disease (CLD)CirrhosisFibrosis
Phase 4
Unknown Phase
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
NCT00635310
Start: 2005-01-31End: 2013-07-31Target: 3520Updated: 2012-12-20
Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors
TerminatedNCT01810640
Start: 2013-02-28End: 2015-02-28Updated: 2015-05-13
Comparison of EUS-Guided Liver Biopsy With Percutaneous Liver Biopsy
WithdrawnNCT02947516
Start: 2017-01-31End: 2018-12-31Updated: 2022-04-19
EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?
CompletedNCT04235855
Start: 2019-10-31End: 2022-01-01Updated: 2022-01-04
EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease
CompletedNCT06047327
Start: 2023-11-01End: 2025-11-30Updated: 2026-01-05
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
CompletedNCT07506642
Start: 2023-09-01End: 2024-09-30Updated: 2026-04-02